Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 4Fabre-Kramer Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

GEPIRONE HYDROCHLORIDE

Brand Name : EXXUA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 18.2MG BASE

Packaging :

Approval Date : 2023-09-22

Application Number : 21164

Regulatory Info : DISCN

Registration Country : USA

blank

02

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

GEPIRONE HYDROCHLORIDE

Brand Name : EXXUA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 36.3MG BASE

Packaging :

Approval Date : 2023-09-22

Application Number : 21164

Regulatory Info : DISCN

Registration Country : USA

blank

03

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

GEPIRONE HYDROCHLORIDE

Brand Name : EXXUA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 54.5MG BASE

Packaging :

Approval Date : 2023-09-22

Application Number : 21164

Regulatory Info : DISCN

Registration Country : USA

blank

04

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

GEPIRONE HYDROCHLORIDE

Brand Name : EXXUA

Dosage Form : TABLET, EXTENDED RELEASE;ORAL

Dosage Strength : EQ 72.6MG BASE

Packaging :

Approval Date : 2023-09-22

Application Number : 21164

Regulatory Info : DISCN

Registration Country : USA

blank